Novartis Investigative Site

Pelotas, Rio Grande do Sul 96015-290

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Atherosclerotic Cardiovascular Disease, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed